Business Context and Reporting Period
Company: Champions Oncology, Inc. (CSBR)
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2025
Reporting Period: Third quarter ended January 31, 2025
Context: The filing discloses the issuance of a press release containing unaudited financial results for the quarter ended January 31, 2025. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in the provided text. The document serves only to announce the availability of the third-quarter results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumed to be within the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 11, 2025) for specific revenue, net loss, and cash position figures.
- Verify the unaudited nature of the financial results for the quarter ended January 31, 2025.
- Check for any forward-looking statements or updated clinical trial milestones in the attached press release.
- Confirm the company's liquidity status and runway based on the cash flow data in the press release.